Analyst Ratings for Rhythm Pharmaceuticals (RYTM)
RYTM Rating Summary
RYTM Price Target Summary
- Highest: $157.00 (Goldman Sachs)
- Lowest: $105.00 (H.C. Wainwright)
- Average: $138.14
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$138.14 (+29.6%)
* Over Last 12-Mos
Rating Score: 9.4 / 10
Percentile Rank: 90%
Avg. $ Target:
$138.14 (+29.6%)
* Over Last 12-Mos
Rating Score: 9.4 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/18/2026 | RBC Capital » Updated 7/7/2026 |
Lisa Walter | New Coverage | Outperform (N/A) |
141.00 (137.00) |
102.53 (106.60) |
3.97% | Details |
| 11/25/2025 | Citi » Updated 3/17/2026 |
Samantha Semenkow | New Coverage | Buy (N/A) |
131.00 (136.00) |
101.74 (106.60) |
4.78% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
